NMC Health Plc provided Post-IFRS 16 and Pre-IFRS 16 earnings guidance for the full year 2019. For the period, on Post-IFRS 16 basis, the company expects revenues to be in the range of USD 2,500 million to USD 2,540 million. Net income to equity holders to be in the range of USD 297 million to USD 305 million. For the period, on Pre-IFRS 16 basis, the company expects revenues to be in the range of USD 2,500 million to USD 2,540 million. Net income to equity holders to be in the range of USD 320 million to USD 330 million.